NCT02352584 - A Multicenter, Double-blind, Parallel Phase III Study | Biotech Hunter

Enrollment

1,299

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

July 31, 2015

Conditions

Influenza

Interventions

BIOLOGICAL

GC3110A(Quadrivalent)

GC3110A(Quadrivalent), 0.5ml, intramuscular, a single dosing at Day 1

BIOLOGICAL

GC Flu(Trivalent)

GC Flu Pre-filled Syringe Inj.(Trivalent), 0.5ml, intramuscular, a single dosing at Day 1

BIOLOGICAL

GC3110A(Trivalent)

GC3110A(Trivalent), 0.5ml, intramuscular, a single dosing at Day 1

Trial Locations (1)

Korea University Guro Hospital, Seoul